ProPhase Labs, Inc. (PRPH) Social Stream
PROPHASE LABS INC (PRPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRPH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 2 | $5 | $5 | $5 | $4.58 | 9.17% |
| 2021-12-20 | 2 | $12 | $5 | $8.5 | $4.58 | 85.59% |
| 2022-02-16 | 2 | $15 | $5 | $10 | $4.58 | 118.34% |
| 2022-04-01 | 2 | $16 | $5 | $10.5 | $4.58 | 129.26% |
| 2022-05-16 | 2 | $14 | $5 | $9.5 | $4.58 | 107.42% |
| 2022-08-15 | 2 | $14 | $5 | $9.5 | $4.58 | 107.42% |
| 2023-03-29 | 1 | $15 | $15 | $15 | $4.58 | 227.51% |
| 2023-10-18 | 1 | $14 | $14 | $14 | $4.58 | 205.68% |
| 2023-11-10 | 1 | $11 | $11 | $11 | $4.58 | 140.17% |
Price Target Last Issued October 18, 2023
The Trend in the Analyst Price Target
PRPH's average price target has moved up $1.5 over the prior 16 months.
PRPH reports an average of 105.38% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-20 | 1 | 15 | 15 | 15 | 10.13 | 48.08% |
| 2023-02-16 | 1 | 15 | 15 | 15 | 7.64 | 96.34% |
| 2023-05-12 | 1 | 14 | 14 | 14 | 7.93 | 76.54% |
| 2023-06-02 | 1 | 14 | 14 | 14 | 8.58 | 63.17% |
| 2023-11-10 | 1 | 11 | 11 | 11 | 4.55 | 141.76% |
PRPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
PRPH's average broker recommendation rating improved by 1 over the prior 21 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PROPHASE LABS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 14.6% of that group.
- To contextualize these metrics, consider that out of all US stocks, PROPHASE LABS INC's variance in analysts' estimates is lower than -246.16% of them.
- PROPHASE LABS INC's average analyst price target is higher than 152.03% of Healthcare stocks.
- In the context of stocks in the micro market cap category, PROPHASE LABS INC's upside potential (average analyst target price relative to current price) is higher than 284.95% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROPHASE LABS INC are SNGX, LTRN, and ADTX.
View All Top Stocks by Price Target
Is PRPH a Buy, Hold or Sell? See the POWR Ratings now!